European Commission Approves CinnaGen’s Zandoriah® (teriparatide biosimilar) for Osteoporosis in Adults

Zandoriah® becomes CinnaGen’s first EU-authorised medicine, reflecting years of investment in infrastructure and manufacturing excellence.